These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36541110)

  • 1. Thirty-two years' experience of treating fulminant hepatitis in a Japanese single center.
    Fujiwara K; Yasui S; Kondo T; Nakamura M; Arai M; Kanda T; Yokosuka O; Ohtsuka M; Abe R; Kato N
    Hepatol Res; 2023 Apr; 53(4):357-369. PubMed ID: 36541110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: Summary of the annual nationwide survey between 2004 and 2009.
    Oketani M; Ido A; Nakayama N; Takikawa Y; Naiki T; Yamagishi Y; Ichida T; Mochida S; Onishi S; Tsubouchi H;
    Hepatol Res; 2013 Feb; 43(2):97-105. PubMed ID: 23409848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant hepatitis and late onset hepatic failure in Japan.
    Fujiwara K; Mochida S; Matsui A; Nakayama N; Nagoshi S; Toda G;
    Hepatol Res; 2008 Jul; 38(7):646-57. PubMed ID: 18328067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune fulminant liver failure in adults: Experience in a Japanese center.
    Fujiwara K; Yasui S; Tawada A; Okitsu K; Yonemitsu Y; Chiba T; Arai M; Kanda T; Imazeki F; Nakano M; Oda S; Yokosuka O
    Hepatol Res; 2011 Feb; 41(2):133-41. PubMed ID: 21269383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe and fulminant hepatitis of indeterminate etiology in a Japanese center.
    Fujiwara K; Yasui S; Nakano M; Yonemitsu Y; Arai M; Kanda T; Fukuda Y; Oda S; Yokosuka O
    Hepatol Res; 2015 Oct; 45(10):E141-9. PubMed ID: 25582192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan.
    Nakao M; Nakayama N; Uchida Y; Tomiya T; Ido A; Sakaida I; Yokosuka O; Takikawa Y; Inoue K; Genda T; Shimizu M; Terai S; Tsubouchi H; Takikawa H; Mochida S
    J Gastroenterol; 2018 Jun; 53(6):752-769. PubMed ID: 29030713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indication criteria for liver transplantation for acute liver failure in Japan.
    Mochida S
    Hepatol Res; 2008 Nov; 38 Suppl 1():S52-5. PubMed ID: 19125953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after living donor liver transplantation for acute liver failure in Japan: results of a nationwide survey.
    Yamashiki N; Sugawara Y; Tamura S; Nakayama N; Oketani M; Umeshita K; Uemoto S; Mochida S; Tsubouchi H; Kokudo N
    Liver Transpl; 2012 Sep; 18(9):1069-77. PubMed ID: 22577093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious complications and timing for liver transplantation in autoimmune acute liver failure in Japan: a subanalysis based on nationwide surveys between 2010 and 2015.
    Fujiwara K; Nakayama N; Kato N; Yokosuka O; Tsubouchi H; Takikawa H; Mochida S;
    J Gastroenterol; 2020 Sep; 55(9):888-898. PubMed ID: 32556645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis.
    Mochida S; Nakayama N; Matsui A; Nagoshi S; Fujiwara K
    Hepatol Res; 2008 Oct; 38(10):970-9. PubMed ID: 18462374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing etiologies and outcomes of acute liver failure: A perspective from Japan.
    Oketani M; Ido A; Tsubouchi H
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():65-71. PubMed ID: 21199516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of the poor prognosis of severe and fulminant hepatitis in the elderly in an era of a highly aging society: Analysis in a Japanese center.
    Fujiwara K; Yasui S; Yonemitsu Y; Arai M; Kanda T; Nakano M; Oda S; Yokosuka O
    Hepatol Res; 2015 Aug; 45(8):863-71. PubMed ID: 25238570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of infectious complications and timing for emergency liver transplantation in autoimmune acute liver failure.
    Fujiwara K; Yasui S; Yonemitsu Y; Arai M; Kanda T; Fukuda Y; Nakano M; Oda S; Yokosuka O
    J Hepatobiliary Pancreat Sci; 2016 Apr; 23(4):212-9. PubMed ID: 26808231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation in adults with acute liver failure: Outcomes from the Argentinean Transplant Registry.
    Mendizabal M; Tagliafichi V; Rubinstein F; Rojas P; Marciano S; Yantorno S; Cejas N; Barrabino M; Anders M; Cairo F; Villamil F; Blazquez L; Zerega A; Ferretti S; Fernández D; Paredes S; Aballay Soteras G; Gaite L; Bisigniano L; Silva MO
    Ann Hepatol; 2019; 18(2):338-344. PubMed ID: 31053539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation: an analysis of 1309 cases in a 15-year national survey.
    Sato S; Suzuki K; Takikawa Y; Endo R; Omata M;
    Hepatol Res; 2004 Nov; 30(3):155-161. PubMed ID: 15588781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical epidemiology of fulminant hepatitis in Japan.
    Takikawa Y; Suzuki K
    Hepatol Res; 2008 Nov; 38 Suppl 1():S14-8. PubMed ID: 19125945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-Onset Hepatic Failure in Children: Risk Factors that Determine the Outcome.
    Singh SK; Sen Sarma M; Yachha SK; Srivastava A; Poddar U
    Dig Dis; 2020; 38(5):415-420. PubMed ID: 31940614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High recovery rate of consciousness by high-volume filtrate hemodiafiltration for fulminant hepatitis.
    Fujiwara K; Abe R; Yasui S; Yokosuka O; Kato N; Oda S
    Hepatol Res; 2019 Feb; 49(2):224-231. PubMed ID: 30277289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety.
    Ido A; Moriuchi A; Numata M; Murayama T; Teramukai S; Marusawa H; Yamaji N; Setoyama H; Kim ID; Chiba T; Higuchi S; Yokode M; Fukushima M; Shimizu A; Tsubouchi H
    J Transl Med; 2011 May; 9():55. PubMed ID: 21548996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in platelet levels and prognosis in patients with acute liver failure and late-onset hepatic failure.
    Hayashi M; Fujita M; Abe K; Takahashi A; Ohira H
    Medicine (Baltimore); 2022 Dec; 101(48):e31438. PubMed ID: 36482586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.